BioSpace News Archive

WHO Warns of Growing Resistance in Individuals to GSK, ViiV’s HIV Drug Tivicay

The World Health Organization has detected signals of growing HIV resistance to GSK and ViiV Healthcare’s Tivicay, which it says must be minimized as part of the broader global response to antimicrobial resistance.

March 6, 2024
·
2 min read
·
Tristan Manalac
Genetown

Nanobiotix to Present at Upcoming Investor Conferences in March 2024

NANOBIOTIX announced that Company management will participate in fireside chats at the upcoming Guggenheim Healthy Altitudes Summit and the Leerink Partners Global Biopharma Conference.

March 6, 2024
·
2 min read
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 34th Annual Healthcare MedTech & Services Conference.

March 6, 2024
·
1 min read
Biotech Beach

Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, will be presenting at the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13th, 2024 at 11:15 am EST.

March 6, 2024
·
4 min read
Business

Endo Reports Fourth-Quarter 2023 Financial Results

Endo International plc reported financial results for the fourth-quarter ended December 31, 2023.

March 6, 2024
·
34 min read
Business

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and fourth quarter and full year 2023 financial results.

March 6, 2024
·
7 min read
Genetown

Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024

Disc Medicine, Inc. (NASDAQ:IRON) announced today that company management will participate in a fireside chat at the Leerink Partners Global Biopharma Conference 2024 on Monday, March 11th at 10:40 am ET.

March 6, 2024
·
1 min read
Policy

FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US

The U.S. Food and Drug Administration is taking several additional steps to address concerns about elevated lead levels in cinnamon following the recent incident associated with certain cinnamon apple sauce pouches that resulted in lead poisoning in young children.

March 6, 2024
·
7 min read
Biotech Bay

ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that management will present a company overview at the Leerink Partners Global Biopharma Conference on Wednesday, March 13, 2024, at 8:00 a.m. ET.

March 6, 2024
·
1 min read
BioForest

Biktarvy® Demonstrates High Rates of Viral Suppression in People With HIV and Comorbidities

Gilead Sciences, Inc. announced new data from three studies evaluating the efficacy and safety profile of Biktarvy® for a broad range of people with HIV, including those with HIV/hepatitis B coinfection and HIV/tuberculosis coinfection.

March 6, 2024
·
16 min read